Agenda Item No: 12.2 REPORT TO: GOVERNING BODY MEETING DATE: 28 January 2019 REPORT TITLE: Chief Officer’s Report SUMMARY OF REPORT: This report provides an update on issues of interest pertinent to Governing Body members which have taken place since the last formal Governing Body Meeting held in November 2018. REPORT RECOMMENDATIONS: Members are requested to note the updates within this report and ratify the adoption of the polices included in section 9 of this report. FINANCIAL IMPLICATIONS: None. REPORT CATEGORY: Tick Formally Receipt x Action the recommendations outlined in the report. x Debate the content of the report Receive the report for information AUTHOR: Debra Atkinson Head of Corporate Business Report supported & approved by your Senior Y Lead PRESENTED BY: Dr Julie Higgins Chief Officer OTHER COMMITTEES/ N/A GROUPS CONSULTED: EQUALITY IMPACT ANALYSIS Has an EIA been completed in respect of this report? N (EIA) : If yes, please attach If no, please provide reason below: Not required RISKS: Have any risks been identified / assessed? N CONFLICT OF INTEREST: Is there a conflict of interest associated with this N report? CLINICAL ENGAGEMENT: Has any clinical engagement/involvement taken Y place as part of the proposal being presented. PATIENT ENGAGEMENT: Has there been any patient engagement associated Y with this report? PRIVACY STATUS OF THE Can the document be shared? Y REPORT: Which Strategic Objective does the report relate to Tick 1 Commission the right services for patients to be seen at the right time, in the right place, X by the right professional. 2 Optimise appropriate use of resources and remove inefficiencies. X 3 Improve access, quality and choice of service provision within Primary Care X 4 Work with colleagues from Secondary Care and Local Authorities to develop seamless X care pathways 1 Agenda Item No: 12.2 East Lancashire Clinical Commissioning Group Governing Body Meeting 28 January 2019 CHIEF OFFICER’S REPORT 1. Introduction 1.1 This report provides an update on issues of interest pertinent to Governing Body members which have taken place since the last formal Governing Body Meeting in November 2018. 2. NATIONAL UPDATES 2.1 £1 billion savings on medicines bill in 2019 A new 5-year deal has been finalised with the pharmaceutical industry to give patients faster access to new medicines. The NHS is expected to save around £930 million on its medicines bill across the UK under a new deal agreed with the pharmaceutical industry. Patients will also have access to new medicines up to 6 months earlier. The government and the Association of the British Pharmaceutical Industry (ABPI) have reached a final agreement in the voluntary scheme for branded medicines pricing and access, which will begin on 1 January 2019 and last for 5 years. In 2019, the following savings are predicted for the NHS medicines bill: England: £744 million Scotland: £93 million Wales: £56 million Northern Ireland: £37 million The scheme is designed to keep growth in the branded medicine bill predictable and affordable by placing a 2% cap on the growth in sales of branded medicines to the NHS. Pharmaceutical companies will repay the NHS for spending above the 2% cap. Other measures to keep the cost of medicines affordable to the NHS include simplifying price controls, and faster and more flexible commercial discussions between the NHS and pharmaceutical companies. The scheme will see the newest and best-value medicines made available to patients on the NHS more quickly through: earlier identification of the most promising medicines being developed earlier commercial discussions with industry faster assessments of the clinical and cost-effectiveness of new medicines by the National Institute for Health and Care Excellence (NICE) Further information via: https://www.gov.uk/government/news/nhs-to-save-1-billion-on-its- medicines-bill-in-2019 2 2.2 Funding to upgrade NHS services in England The Health and Social Care Secretary Matt Hancock announced in December £963 million of extra funding for health facilities across England. Stopping sending money to the EU after EU Exit means we can invest more in domestic priorities including our NHS. A total of 75 projects will receive funding to upgrade facilities so that more people can be treated and more can be done to prevent ill-health in the first place. Almost £800 million of the funding will go to projects outside London in order to improve access to care across the country. Funding has been given to five trusts in the north west of England, of which two are in Lancashire and South Cumbria; £12.9m to Blackpool Teaching Hospitals NHS Foundation Trust for the Fylde Coast emergency department and critical care scheme £8.1m to Lancashire Care NHS Foundation Trust for the Fylde Coast Integrated Acute Mental Health Hub. The investment came ahead of the launch of the ong-term plan for the NHS. The long-term plan is the biggest ever funding increase for the NHS and will see its budget increase by £20.5 billion every year by 2023 to 2024. More information via: https://www.gov.uk/government/news/1-billion-of-funding-to-upgrade- nhs-services-in-england 2.3 Brexit Operational Readiness Guidance for the Health and Care System Guidance has been released from Sir Chris Wormald, the Permanent Secretary. This follows from the Secretary of State, Matt Hancock’s, letter on Governments preparations for a March 2019 ‘no deal’ scenario, which focussed on supply chain implications and boarder planning assumptions to industry and the health and care system. The EU Exit Operational Readiness Guidance has been developed and agreed with NHS England and NHS Improvement to set out local actions that providers and commissioners of health and adult social care service should take to prepare for the EU exit. NHS England and NHS Improvement are to establish regional and national teams to enable rapid support on emerging local incidents and escalation to the new Operational Response Centre. The letter confirms that delivering the delivering the deal remains the government’s top priority and is the best ‘no deal’ mitigation. But in line with the government’s principal operational focus on national ‘no deal’ planning, actions must be taken locally to manage risks of a ‘no deal’ exit. Within East Lancashire work has already begun in support of this, through the Business Impact Analyses (BIA) undertaken by CCG managers, in assessing critical functions for business continuity in case of a major incident and, through collation of information for the submission of the Emergency Preparedness, Resilience and Response (EPRR) Core Standards (in October 2018). Next steps are to review the CCGs business continuity management system, along with partners and providers, and escalate any significant issues that may arise from a ‘No Deal’ exit. Every service can potentially be affected by one or more of the above and there are no exceptions to completing a revised Business Impact Analysis with immediate effect. 3 There is support available for all teams to complete these; The [Pennine Lancs CCG] EPRR Task & Finish Group will coordinate the responses. Further operational guidance will be provided to support the health and care system to prepare for the UK leaving the EU before 29 March 2019. Further information via: https://www.gov.uk/government/publications/brexit-operational- readiness-guidance-for-the-health-and-social-care-system-in-england 2.4 Chief Medical Officer – Annual Report 2018: Better Health Within Reach Professor Dame Sally Davies’s tenth report as Chief Medical Director was published on 21 December 2018. The report is independent of the government and is aimed at government regulators, policy makers and healthcare professionals. The recommendations are targeted at specific organisations. The report has been developed with the help of expert academic input. There are 4 main sections in the report, discussing: health as the nation’s primary asset the health environment we live in and build together using emerging technologies to improve health for everyone effective planning for the future The report concludes that there are reasons to be optimistic but that greater effort to improve the health environment is required – it should be easier to take the healthy option. Further information via: https://www.gov.uk/government/publications/chief-medical-officer- annual-report-2018-better-health-within-reach 3. NHS England 3.1 NHS Executive Group NHS England and NHS Improvement have announced the appointments to their new senior leadership team, the NHS Executive Group. As part of closer working arrangements between the two organisations, NHS England and NHS Improvement will share the new combined management group chaired by the two Chief Executives. Appointments were announced as follows; NHS Executive Group: NHS Chief Financial Officer – Julian Kelly National NHS Medical Director – Professor Stephen Powis Chief Nursing Officer – Ruth May Deputy Chief Executive, NHS England – Matthew Swindells National Director for Emergency & Elective Care – Pauline Philip National Director for Strategy & Innovation – Ian Dodge National Director for Transformation & Corporate Development – Emily Lawson Recruitment is underway for the remaining positions on the NHS Executive Group: Chief Commercial Officer Chief Improvement Officer Chief People Officer Chief Provider Strategy Officer Strong leaders will head up seven regional teams, integrating NHS England and NHS Improvement. They will play a major leadership role in geographies,